Equities analysts expect MINDBODY Inc (NASDAQ:MB) to report earnings per share (EPS) of ($0.07) for the current quarter, Zacks reports. Seven analysts have made estimates for MINDBODY’s earnings. The lowest EPS estimate is ($0.08) and the highest is ($0.07). MINDBODY reported earnings of $0.01 per share during the same quarter last year, which would suggest a negative year-over-year growth rate of 800%. The firm is scheduled to issue its next quarterly earnings report on Thursday, October 25th.

On average, analysts expect that MINDBODY will report full-year earnings of ($0.13) per share for the current fiscal year, with EPS estimates ranging from ($0.15) to ($0.11). For the next fiscal year, analysts forecast that the company will report earnings of $0.02 per share, with EPS estimates ranging from ($0.08) to $0.06. Zacks’ EPS calculations are an average based on a survey of research analysts that cover MINDBODY.

MINDBODY (NASDAQ:MB) last posted its earnings results on Tuesday, July 31st. The technology company reported ($0.22) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.18) by ($0.04). MINDBODY had a negative return on equity of 6.83% and a negative net margin of 11.85%. The firm had revenue of $61.61 million during the quarter, compared to the consensus estimate of $60.48 million.

Several equities research analysts have recently weighed in on the stock. Zacks Investment Research raised shares of MINDBODY from a “sell” rating to a “hold” rating in a report on Thursday, July 12th. Wells Fargo & Co began coverage on shares of MINDBODY in a research report on Friday. They set an “outperform” rating and a $45.00 price target on the stock. BidaskClub downgraded shares of MINDBODY from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, August 1st. KeyCorp reiterated a “buy” rating and set a $47.00 price target on shares of MINDBODY in a research report on Wednesday, August 1st. Finally, Morgan Stanley reduced their price target on shares of MINDBODY from $42.00 to $40.00 and set an “equal weight” rating on the stock in a research report on Wednesday, August 1st. Four research analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has issued a strong buy rating to the company. The stock presently has an average rating of “Buy” and an average target price of $38.38.

MB opened at $38.65 on Friday. The company has a debt-to-equity ratio of 0.86, a quick ratio of 9.61 and a current ratio of 9.61. MINDBODY has a twelve month low of $23.75 and a twelve month high of $45.50. The stock has a market capitalization of $1.79 billion, a PE ratio of -128.83 and a beta of -0.19.

In other MINDBODY news, CEO Richard Lee Stollmeyer sold 17,739 shares of the company’s stock in a transaction dated Monday, July 2nd. The shares were sold at an average price of $38.96, for a total transaction of $691,111.44. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, major shareholder Luxor Capital Group, Lp bought 65,019 shares of the business’s stock in a transaction on Wednesday, August 1st. The shares were acquired at an average price of $34.86 per share, for a total transaction of $2,266,562.34. The disclosure for this purchase can be found here. In the last quarter, insiders have sold 56,618 shares of company stock worth $2,080,684. 6.02% of the stock is owned by corporate insiders.

A number of institutional investors have recently added to or reduced their stakes in the business. Nelson Roberts Investment Advisors LLC lifted its position in MINDBODY by 1.1% during the 2nd quarter. Nelson Roberts Investment Advisors LLC now owns 123,901 shares of the technology company’s stock valued at $4,783,000 after purchasing an additional 1,325 shares during the period. Commonwealth Equity Services LLC lifted its position in MINDBODY by 16.5% during the 1st quarter. Commonwealth Equity Services LLC now owns 9,466 shares of the technology company’s stock valued at $368,000 after purchasing an additional 1,343 shares during the period. Rhumbline Advisers lifted its position in MINDBODY by 4.4% during the 2nd quarter. Rhumbline Advisers now owns 41,030 shares of the technology company’s stock valued at $1,584,000 after purchasing an additional 1,737 shares during the period. Schwab Charles Investment Management Inc. lifted its position in MINDBODY by 1.2% during the 1st quarter. Schwab Charles Investment Management Inc. now owns 173,190 shares of the technology company’s stock valued at $6,738,000 after purchasing an additional 2,031 shares during the period. Finally, Arthur M. Cohen & Associates LLC increased its stake in shares of MINDBODY by 27.8% in the 2nd quarter. Arthur M. Cohen & Associates LLC now owns 11,500 shares of the technology company’s stock valued at $444,000 after acquiring an additional 2,500 shares during the last quarter. Institutional investors own 96.74% of the company’s stock.

MINDBODY Company Profile

MINDBODY, Inc operates a cloud-based business management software and payments platform for the small and medium-sized businesses in the wellness services industry. Its platform enables businesses to run, market, and build scheduling and online booking, performance tracking, staff management, client relationship management, integrated payment processing, retail point-of-sale, purchase tracking, inventory, hardware integration, analytics and reporting, branded Web, mobility, social integration, client acquisition dashboard, security and compliance, and integration with other cloud-based partners for yoga, Pilates, indoor cycling, group and personal training, boutique fitness, salons, spas, and integrative health businesses.

Featured Article: What is a Tariff?

Get a free copy of the Zacks research report on MINDBODY (MB)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for MINDBODY (NASDAQ:MB)

Receive News & Ratings for MINDBODY Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MINDBODY and related companies with MarketBeat.com's FREE daily email newsletter.